Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization

• Main Authors: Turner, Hannah L. (Author), Andrabi, Raiees (Author), Cottrell, Christopher A. (Author), Richey, Sara T. (Author), Song, Ge (Author), Callaghan, Sean (Author), Anzanello, Fabio (Author), Moyer, Tyson J. (Author), Abraham, Wuhbet (Author), Melo, Mariane Bandeira (Author), Silva, Murillo (Author), Scaringi, Nicole (Author), Rakasz, Eva G. (Author), Sattentau, Quentin J. (Author), Irvine, Darrell J (Author), Burton, Dennis R. (Author), Ward, Andrew B. (Author)
• Other Authors: Koch Institute for Integrative Cancer Research at MIT (Contributor), Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Materials Science and Engineering (Contributor)
• Format: Article
• Language: English
• Published: American Association for the Advancement of Science (AAAS), 2021-08-31T17:06:16Z.
• Subjects: Article
• Online Access: Get fulltext

Rationally designed protein subunit vaccines are being developed for a variety of viruses including influenza, RSV, SARS-CoV-2, and HIV. These vaccines are based on stabilized versions of the primary targets of neutralizing antibodies on the viral surface, namely, viral fusion glycoproteins. While these immunogens display the epitopes of potent neutralizing antibodies, they also present epitopes recognized by non-neutralizing or weakly neutralizing ("off-target") antibodies. Using our recently developed electron microscopy polyclonal epitope mapping approach, we have uncovered a phenomenon wherein off-target antibodies elicited by HIV trimer subunit vaccines cause the otherwise highly stabilized trimeric proteins to degrade into cognate protomers. Further, we show that these protomers expose an expanded suite of off-target epitopes, normally occluded inside the prefusion conformation of trimer, that subsequently elicit further off-target antibody responses. Our study provides critical insights for further improvement of HIV subunit trimer vaccines for future rounds of the iterative vaccine design process.
NIH (Grants UM1AI100663 and UM1AI144462)
Bill and Melinda Gates Foundation (Grants OPP1115782, INV-002916, OPP1170236 and OPP1206647)